Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Two more Fortis...

    Two more Fortis directors quit ahead of crucial EGM today

    Written by Ruby Khatun Khatun Published On 2018-05-22T10:30:55+05:30  |  Updated On 22 May 2018 10:30 AM IST
    Two more Fortis directors quit ahead of crucial EGM today

    New Delhi: Fortis Healthcare Monday said its two more directors, Harpal Singh and Sabina Vaisoha, have resigned — a day ahead of a crucial meeting of shareholders called to vote on the removal of four directors of the cash-strapped healthcare chain.


    Tejinder Singh Shergill had resigned Sunday. He was among the four directors along with Singh, Vaisoha, and Brian Tempest whose removal has been sought by investors National Westminster Bank Plc as trustee of Jupiter India Fund and East Bridge Capital Master Fund.


    The two institutional investors, which together hold 12.04 percent stake in Fortis Healthcare, had demanded last month that these four directors be removed from the board and had called for the company’s EGM on May 22 for shareholders to vote.


    These investors had sought the removal of the directors for allegedly failing to work in the interest of all shareholders, particularly in their handling of the hospital chain’s proposed sale.


    At the same time, these two institutions had also sought to seek shareholders’ nod for appointment of three directors — Suvalaxmi Chakraborty, Ravi Rajagopal and Indrajit Banerjee to the company’s board.


    In a BSE filing, Fortis said Singh, who is also Chairman Emeritus of the company, has resigned as a non-executive director with effect from May 20 citing personal reasons.


    Similarly, Vaisoha also put in her papers to step down as non-executive independent director on the company’s board, the company said in a separate filing.


    Singh in his resignation letter to fellow board members said that “despite delivering a good outcome for the company and its shareholders there still persist some less informed attempts to steer the board and the company into a situation that could be perilous for the company’s future”.


    He also defended the board’s decision to go with the final Munjal-Burman bid saying it “was selected on criteria of certainty, the simplicity of structure, no walk away rights, an early infusion of funds, capacity to address strategic needs and the ability to traverse a challenging landscape”


    Vaisoha in her resignation letter said: “As the shareholders have expressed the desire to bring in a new board, I welcome their decision and I would be happy to step down from the board.”


    Shergill had resigned from the board citing personal reasons.


    Earlier this month, the four directors had sent a joint representation to the shareholders of the company refuting allegations of not exercising their fiduciary duties and stated that they fairly represent interests of all shareholders.


    They had also claimed that the change of the entire board at this time will certainly bring more turbulence and ambiguity to Fortis as well as its management.


    They had asked shareholders to take an informed decision while voting on a resolution seeking their removal.


    Fortis Healthcare is trying to finalize a new owner after receiving bids from five suitors, which included Manipal-TPG combine, Malaysia’s IHH Healthcare, KKR-backed Radiant Life Care, China’s Fosun Healthcare besides the successful bidder Munjals-Burmans combine.

    DirectorsEast Bridge Capital Master FundEGMFortisFortis boardFortis HealthcareJupiter India FundresignedshareholdersTejinder Singh Shergill
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok